Anthony Son

AnthonySon

Anthony Son is a distinguished professional specializing in Intellectual Property Law, particularly in Software License Agreements. As the Owner of Son IP Group, Anthony brings extensive expertise in areas such as Commercial Litigation, Patent Litigation, and Licensing.

With a solid background in Financial Services and a knack for Outside General Counsel services, Anthony is renowned for his strategic legal counsel and adept handling of complex litigation matters. He has garnered numerous endorsements in Intellectual Property, Trade Secrets, and Legal Research, reflecting his deep understanding and proficiency in these areas.

Anthony's dedication to his craft is evident in his commitment to staying abreast of legal developments and his meticulous approach to Legal Writing and Patent Prosecution. His diverse skill set also extends to Patentability assessments, Trademarks, and Civil Litigation, making him a valuable asset to clients seeking comprehensive legal solutions.


Areas of Practice:
  • Intellectual Property
  • Software License Agreements
  • Commercial Litigation
  • Patent Litigation
  • Licensing
  • Trade Secrets
  • Trademarks
Education:
  • Yeshiva University, Benjamin N. Cardozo School of Law
  • Univ of Maryland Baltimore Co

Defenses to Performance of COVID-19 Impacted Contracts

December 20, 2022

A recent decision by an Orange County Superior Court judge confirms the viability of the defenses of impossibility or impracticability of performance of certain COVID-19 impacted contracts, and finds a…

Subject matter eligibility for obtaining patent protection

June 23, 2022

The U.S. Supreme Court has strongly indicated that it intends to grant a writ of certiorari to review a ruling by the Federal Circuit court of appeal, dealing with subject…

Controversy Over Overriding Intellectual Property Protections for COVID-19 Vaccines, Diagnostics and Treatments

August 12, 2021

A recent proposal by the U.S. government to the World Trade Organization (WTO) to direct its member states to override patent protections for COVID-19 vaccines, and a competing proposal by…